ArticleInvestigational new drugs2020
Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells.
Feng Qu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it